Search Login Register

Thrombosis (Thrombus) Summary

Description: Formation and development of a thrombus or blood clot in the blood vessel.

Also Known As: Thrombus; Thromboses

Networked: 46697 relevant articles (1961 outcomes, 3713 trials/studies) for this Disease

Key Drugs and Agents for Thrombosis

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Heparin (Liquaemin) : 179 outcomes 221 studies in 2950 results : FDA 74 Generic
  2. Aspirin (Acetylsalicylic Acid) : 86 outcomes 116 studies in 1153 results : FDA 80 Generic
  3. glucuronyl glucosamine glycan sulfate (Vessel) : 70 outcomes 132 studies in 2720 results : IBA
  4. Warfarin (Coumadin) : 66 outcomes 78 studies in 790 results : FDA 21 Generic
  5. Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight) : 65 outcomes 97 studies in 636 results : IBA
  6. Thrombin : 56 outcomes 98 studies in 1356 results : FDA 2
  7. Urokinase-Type Plasminogen Activator (Urokinase) : 55 outcomes 26 studies in 507 results : FDA 2
  8. clopidogrel (Plavix) : 52 outcomes 91 studies in 698 results : FDA 7
  9. Tissue Plasminogen Activator (Alteplase) : 42 outcomes 49 studies in 630 results : FDA 2
  10. Streptokinase : 39 outcomes 22 studies in 379 results : FDA 1
Show All >>

Diseases Related to Thrombosis

  1. Neoplasms (Cancer)
  2. Myocardial Infarction
  3. Hemorrhage
  4. Thrombosis (Thrombus)
  5. Venous Thrombosis (Deep-Vein Thrombosis)
Show All >>

Key Therapies for Thrombosis

Efficacy Chart >>
  1. Stents : 313 outcomes 651 studies in 6749 results
  2. Transplants (Transplant) : 149 outcomes 225 studies in 4264 results
  3. Catheters : 139 outcomes 202 studies in 2909 results
  4. Thrombectomy : 75 outcomes 75 studies in 1135 results
  5. Angioplasty (Angioplasty, Transluminal) : 51 outcomes 56 studies in 770 results
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.